Category: Penny Stock NewsSort
Praxair (PX) Subsidiary Praxair Distribution Acquiresd PortaGas
EMCOR Group (EME) Subsidiary Dynalectric Company Awarded 2 Contracts
Southcross Energy Partners (SXE) Reports 3Q 2012 Results
NuStar (NS) to Expand Its Eagle Ford Crude Oil Pipeline System
Ducommun (DCO) Awarded $15M in Contracts from Raytheon
BioScrip (BIOS) Entered Agreement to Acquire HomeChoice Partners
Advaxis is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.